Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare Biotechnology
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Revive Therapeutics Ltd > RVV HOUSE POSITIONS TODAY WHO MADE MONEY & LOST MONEY
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(868)
•••
Post by moneynorthboundon Jan 05, 2021 9:00pm
254 Views
Post# 32230033

RVV HOUSE POSITIONS TODAY WHO MADE MONEY & LOST MONEY

RVV HOUSE POSITIONS TODAY WHO MADE MONEY & LOST MONEY
From:  To:  

947,735 ($603,472) RVV.CN shares exchanged hands today.
House Bought Sold Net 
House 002
RBC
Bought $167,921
Volume 264,042
Average $0.636
Sold $64,682
Volume 101,197
Average $0.639
Net $103,239
Volume 162,845
 
House 079
CIBC
Bought $99,622
Volume 153,711
Average $0.648
Sold $69,035
Volume 106,778
Average $0.647
Net $30,587
Volume 46,933
 
House 001
Anonymous
Bought $93,770
Volume 147,500
Average $0.636
Sold $77,905
Volume 120,500
Average $0.647
Net $15,865
Volume 27,000
 
House 033
Canaccord
Bought $11,980
Volume 19,000
Average $0.631
Sold 0
Volume 0
Average 0
Net $11,980
Volume 19,000
 
House 085
Scotia
Bought $60,310
Volume 95,234
Average $0.633
Sold $52,016
Volume 81,739
Average $0.636
Net $8,294
Volume 13,495
 
House 080
National Bank
Bought $10,730
Volume 17,000
Average $0.631
Sold $4,160
Volume 6,500
Average $0.640
Net $6,570
Volume 10,500
 
House 009
BMO Nesbitt
Bought $14,456
Volume 22,946
Average $0.630
Sold $8,717
Volume 13,825
Average $0.631
Net $5,739
Volume 9,121
 
House 019
Desjardins
Bought $8,450
Volume 13,000
Average $0.650
Sold $2,714
Volume 4,310
Average $0.630
Net $5,736
Volume 8,690
 
House 089
Raymond James
Bought $26,722
Volume 42,616
Average $0.627
Sold $25,770
Volume 40,000
Average $0.644
Net $952
Volume 2,616
 
House 084
Ind Trading
Bought $1,280
Volume 2,000
Average $0.640
Sold 0
Volume 0
Average 0
Net $1,280
Volume 2,000
 
House 014
ITG
Bought $950
Volume 1,500
Average $0.633
Sold 0
Volume 0
Average 0
Net $950
Volume 1,500
 
House 039
Merrill Lynch
Bought 0
Volume 0
Average 0
Sold $356
Volume 532
Average $0.669
Net $-356
Volume -532
 
House 036
Latimer
Bought $1,161
Volume 1,810
Average $0.641
Sold $5,582
Volume 8,706
Average $0.641
Net $-4,421
Volume -6,896
 
House 088
Credential
Bought $2,681
Volume 4,200
Average $0.638
Sold $10,530
Volume 16,500
Average $0.638
Net $-7,849
Volume -12,300
 
House 124
Questrade
Bought $6,227
Volume 9,876
Average $0.631
Sold $22,196
Volume 34,725
Average $0.639
Net $-15,969
Volume -24,849
 
House 007
TD Sec
Bought $97,212
Volume 153,300
Average $0.634
Sold $259,809
Volume 412,423
Average $0.630
Net $-162,597
Volume -259,123
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities